References
- Meier B. Plaque sealing by coronary angioplasty. Heart 2004; 90: 1395–8
- Little W. C., Constantinescu M., Applegate R. J. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild‐to‐moderate coronary artery disease?. Circulation 1988; 78: 1157–66
- Ellis S., Alderman E., Cain K., Fisher L., Sanders W., Bourassa M. Prediction of risk of anterior myocardial infarction by lesion severity and measurement method of stenoses in the left anterior descending coronary distribution: a CASS Registry Study. J Am Coll Cardiol 1988; 11: 908–16
- Hamon M., Bauters C., McFadden E. P., Lablanche J. M., Bertrand M. E. Six‐month quantitative angiographic follow‐up of <50% diameter stenoses dilated during multilesion percutaneous transluminal coronary angioplasty. Am J Cardiol 1993; 71: 1226–9
- Meier B. Ramamurthy S. Plaque sealing by coronary angioplasty. Cathet Cardiovasc Diagn 1995; 36: 295–7
- Ischinger T., Gruentzig A. R., Hollman J. Should coronary arteries with less than 60% diameter stenosis be treated by angioplasty?. Circulation 1983; 68: 148–54
- Mercado N., Maier W., Boersma E. Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J 2003; 24: 541–51
- Bech G. J., De Bruyne B., Pijls N. H. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 2001; 103: 2928–34
- Kastrati A., Mehilli J., von Beckerath N. Sirolimus‐eluting stent or paclitaxel‐eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in‐stent restenosis: a randomized controlled trial. JAMA 2005; 293: 165–71
- Iakovou I., Ge L., Michev I. Clinical and angiographic outcome after sirolimus‐eluting stent implantation in aorto‐ostial lesions. J Am Coll Cardiol 2004; 44: 967–71
- Colombo A., Iakovou I. Drug‐eluting stents: the new gold standard for percutaneous coronary revascularisation. Eur Heart J 2004; 25: 895–7
- Stone G. W., Ellis S. G., Cox D. A. A polymer‐based, paclitaxel‐eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221–31
- Morice M. C., Serruys P. W., Sousa J. E. A randomized comparison of a sirolimus‐eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773–80
- Hoye A., Lemos P. A., Arampatzis C. A. Effectiveness of sirolimus‐Eluting stent implantation for coronary narrowings<50% in diameter. Am J Cardiol 2004; 94: 112–4
- O'Neill W. W., Leon M. B. Drug‐eluting stents: costs versus clinical benefit. Circulation 2003; 107: 3008–11
- Virmani R., Guagliumi G., Farb A. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus‐eluting stent: should we be cautious?. Circulation 2004; 109: 701–5
- Iakovou I., Schmidt T., Bonizzoni E. Incidence, Predictors, and Outcome of Thrombosis after Successful Implantation of Drug‐Eluting Stents. JAMA 2005; 293: 2126–30
- Jeremias A., Sylvia B., Bridges J. Stent thrombosis after successful sirolimus‐eluting stent implantation. Circulation 2004; 109: 1930–2
- Ong A. T., Hoye A., Aoki J. Thirty‐day incidence and six‐month clinical outcome of thrombotic stent occlusion after bare‐metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005; 45: 947–53